Following the resignation of its chairman yesterday, Sigma Pharmaceuticals Ltd
(ASX:SIP) has reported receiving a takeover approach this morning.
In a statement to the ASX, the private hospitals and pathology provider says it has received a non-binding, indicative and conditional proposal to acquire all of the issued share capital of Sigma for an indicative price of $0.60 a share under a scheme of arrangement.
Sigma says its board it considering the proposal and recommends that shareholders take no action at this stage.
Just yesterday the company announced that chairman Dr John Stocker and non-executive director Doug Curlewis would retire at the company’s annual general meeting on June 21.
The resignations follow those of the CEO and CFO early in the year after Sigma’s $389 million full year loss.
For the 12 months to January 30, 2010, Sigma Pharmaceuticals paid a total of $0.03 a share in dividends to shareholders.
